Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Shutterstock/Yoottana Tiyaworanan
Superbugs

10 million people could die every year due to resistance to antibiotics

The overuse of antibiotics means common infections are becoming deadly.

TEN MILLION PEOPLE could die every year from 2050 onwards unless sweeping global changes are agreed to tackle increasing resistance to antibiotics.

That’s according to a new report that claims the issue is turning common ailments into killers.

The Review on Antimicrobial Resistance, which was commissioned by the British government, sets out steps to fight the emergence of so-called superbugs as infections become immune to existing drugs, allowing minor injuries and common infections to become deadly.

“It needs to be seen as the economic and security threat that it is, and be at the forefront of the minds of heads of state,” Jim O’Neill, the economist who led the review, wrote.

The overuse of antibiotics should be reduced by cutting the vast quantities of medicines given to farm animals, improving diagnoses to stop unnecessary prescriptions, and a global public awareness campaign, the paper urged.

At the same time, researchers should be encouraged to develop new antibiotics through a global fund for research and rewards for those who manage to develop new drugs.

Need to act now

The cost of the measures was estimated to be €35.6 billion over 10 years — far less than the cost if the growing problem is not addressed.

“There is no excuse for inaction given what we know about the impact of rising drug resistance,” the paper said. Governments will face the cost “sooner or later”, it added.

They can either do so proactively by taking action now and pay less for better outcomes, or remain unprepared and end up spending much more taxpayer money on far worse outcomes further down the line.

The paper argued that the response could be funded through countries’ health budgets or through taxes on pharmaceutical companies that do not invest on antibiotic research.

O’Neill, an economist known for coining the term BRIC to describe large emerging countries (Brazil, Russia, India and China) and who was asked by the British government to chair the review, noted that one million people had died of antimicrobial resistance since the review started in mid-2014.

The World Health Organization (WHO) has already warned antimicrobial resistance may result in “a return to the pre-antibiotic era”, when millions of people died in pandemics before drugs were discovered that could treat them.

© AFP 2016

Read: Twitter accounts linked to detective garda used to mock Clare Daly after arrest

Read: Man in America accidentally livestreams birth of his child to thousands of people

Your Voice
Readers Comments
53
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.